Located on the same plot of land as the current facility, the extension, unofficially named “Oss2” will double the capacities of the facility’s current operation, helping Movianto Netherlands adapt to the ever-evolving market.
The project is built on a solid foundation: the original Oss facility offers, among other services, strategic market access, specific distribution expertise on biotech, diagnostics, and other healthcare-related products, and manufacturing capabilities, all serving the current needs of Movianto’s Dutch and international clients.
The extension will expand the different temperature ranges, including deep freeze capacities, as more and more products require this kind of storage. Additionally, and importantly, a bunker is being built for dangerous goods to comply with new Dutch regulation on those products. Finally, the facility will be equipped with cutting edge automation and technology.
“We are incredibly proud of the progress of the expansion. Thanks to significant positive commercial developments, the decision was made to increase the storage capacity within the building by using narrow aisles. This will allow us to better accommodate the growth of our existing clients. To this end, we have extended the completion date to the 2nd quarter of 2023. The roof is now closed and we can see that the outer walls are also almost completely up. In a short while we can really start working inside!”
Patrick Verkuijlen, Managing Director Movianto Benelux
From the start, the extension of Oss has aimed to be the most environmentally friendly project that Movianto has conceived of to date. Thanks to the landlord, construction partners, and the ingenuity of the development team, every detail of the project has been examined for its environmental impact. At every stage of the process, the team asked, “How can we make this more sustainable?”
“At Movianto, we believe there is no such thing as too small of a gesture for the planet. This extension is an opportunity for us to try as many new initiatives as we can, determine best practices, and then incorporate them into our Coninuous Improvement program to be later disseminated group-wide,” said Patrick Verkuijlen, Managing Director of Movianto Benelux.
Here are just some examples of Oss2’s sustainability features:
The keystone to the new Oss site is the cold production of Movianto’s warehouses. This temperature-controlled environment is essential for the distribution of healthcare products and is very energy intensive. Movianto turned to their partner Voets & Donkers and they offered a sustainable solution.
Movianto is part of the Walden Group, founded in 1951. With its one-stop-shop service for the distribution of healthcare products, Walden is now Europe’s market leader for logistics and transport in the pharmaceutical and healthcare industry. Movianto aims to be the preferred European logistics partner for this industry and to offer the best service for pharmaceutical as well as biotechnical products, for medical technology as well as for diagnostics. Along the logistics chain of such products, Movianto as an outsourcing partner offers, for example, warehouse logistics and transport (also temperature-controlled), but also complete solutions such as order to cash or purchasing and procurement services. Movianto’s international clients benefit from a pan-European network, a wide range of pharmaceutical logistics, unique industry know-how and standardised processes in accordance with quality standards such as ISO 9001 and ISO 13485. Movianto employs more than 3,200 people, has space for more than 630,000 pallets in its network of 23 company-owned logistics centres in eleven European countries and operates throughout Europe.
Walden is a family-owned group of companies consisting of six different operating companies, all specialising in logistics and transport solutions for the pharmaceutical and healthcare industries. Walden has 70 years of experience in this field and is today Europe’s market leader with its own logistics centres in 12 countries, more than 5,000 employees and a turnover of 1.7 billion euros in 2020. The group is today led by Stéphane Baudry, the grandson of the founder. With numerous investments, Walden has developed, among other things, digital solutions to increase the safety and quality of its subsidiaries’ processes. The company is committed to the values of integrity, quality and innovation in the service of healthcare.
We will be glad to support you with your information requirements.